Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLPG1205 in moderate to severe ulcerative colitis
NCT02337608Phase 2Completed
- Sponsor
- Galapagos NV
- Start
- Dec 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of GLPG1205 in ulcerative colitis (UC), sponsored by Galapagos NV. Started Dec 2014; status: completed.
02
Drugs
GLPG1205
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02337608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02337608.